Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy.
Jamieson C, Drummond F, Hills T, Ozolina L, Gilchrist M, Seaton RA, Santillo M, Wilkinson AS, Allwood MC. Jamieson C, et al. Among authors: wilkinson as. JAC Antimicrob Resist. 2021 Sep 27;3(3):dlab141. doi: 10.1093/jacamr/dlab141. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34676364 Free PMC article.
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements.
Jamieson C, Ozolina L, Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS; BSAC Drug Stability Testing Working Group. Jamieson C, et al. Among authors: wilkinson as. Eur J Hosp Pharm. 2022 Jul;29(4):212-216. doi: 10.1136/ejhpharm-2020-002340. Epub 2020 Sep 25. Eur J Hosp Pharm. 2022. PMID: 32978220 Free PMC article.
Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T, Jamieson C; BSAC Drug Stability Working Party. Allwood MC, et al. Among authors: wilkinson as. Eur J Hosp Pharm. 2020 Mar;27(2):90-94. doi: 10.1136/ejhpharm-2018-001515. Epub 2018 Sep 18. Eur J Hosp Pharm. 2020. PMID: 32153771 Free PMC article.
Investigation of meropenem stability after reconstitution: the influence of buffering and challenges to meet the NHS Yellow Cover Document compliance for continuous infusions in an outpatient setting.
Jamieson C, Allwood MC, Stonkute D, Wallace A, Wilkinson AS, Hills T; BSAC Drug Stability Working Party. Jamieson C, et al. Among authors: wilkinson as. Eur J Hosp Pharm. 2020 Mar;27(e1):e53-e57. doi: 10.1136/ejhpharm-2018-001699. Epub 2019 Jan 13. Eur J Hosp Pharm. 2020. PMID: 32296506 Free PMC article.
TMEM65 regulates NCLX-dependent mitochondrial calcium efflux.
Garbincius JF, Salik O, Cohen HM, Choya-Foces C, Mangold AS, Makhoul AD, Schmidt AE, Khalil DY, Doolittle JJ, Wilkinson AS, Murray EK, Lazaropoulos MP, Hildebrand AN, Tomar D, Elrod JW. Garbincius JF, et al. Among authors: wilkinson as. bioRxiv [Preprint]. 2023 Oct 9:2023.10.06.561062. doi: 10.1101/2023.10.06.561062. bioRxiv. 2023. PMID: 37873405 Free PMC article. Preprint.
33 results